Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zogenix Inc (NASDAQ:ZGNX)

10.35
Delayed Data
As of Jan 13
 -1.15 / -10.00%
Today’s Change
7.33
Today|||52-Week Range
13.70
-14.81%
Year-to-Date
No recent news for Zogenix Inc.

Today’s Trading

Previous close11.50
Today’s open11.50
Day’s range10.15 - 11.70
Volume589,449
Average volume (3 months)214,916
Market cap$256.6M
Dividend yield--
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)-578.65%
Earnings growth (this year)-318.58%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-31.70%
P/E ratioNM
Price/Sales11.42
Price/Book1.40

Competitors

 Today’s
change
Today’s
% change
ASMBAssembly Biosciences...+0.78+5.66%
STMLStemline Therapeutic...-0.30-2.26%
ESPREsperion Therapeutic...-0.21-1.72%
TGTXTG Therapeutics Inc+0.20+4.21%
Data as of 4:00pm ET, 01/13/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.81
Annual revenue (last year)$27.7M
Annual profit (last year)-$49.3M
Net profit margin-150.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Stephen J. Farr
CFO, Secretary, Treasurer &
Executive VP
Ann D. Rhoads
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs